The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer

BACKGROUND: The epidermal growth factor receptor (EGFR) is a potential target of anticancer therapy in gastric cancer. However, its prognostic role in metastatic gastric or gastroesophageal junction (GE) cancer has not been established yet. METHODS: EGFR status was analyzed by immunohistochemistry (...

Descripción completa

Detalles Bibliográficos
Autores principales: Atmaca, Akin, Werner, Dominique, Pauligk, Claudia, Steinmetz, Kristina, Wirtz, Ralph, Altmannsberger, Hans-Michael, Jäger, Elke, Al-Batran, Salah-Eddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529672/
https://www.ncbi.nlm.nih.gov/pubmed/23153332
http://dx.doi.org/10.1186/1471-2407-12-524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529672/
https://www.ncbi.nlm.nih.gov/pubmed/23153332
http://dx.doi.org/10.1186/1471-2407-12-524

Ejemplares similares